Nobilis Rismavac +CA126 consists of a suspension of living cultured avian cells containing attenuated Marek's Disease virus and Turkey Herpes Virus.
Nobilis Rismavac+CA126 is supplied in frozen ampoules held in metal canes stored in a liquid nitrogen canister. Solvent CA is supplied for reconstitution of the vaccine prior to use.
Nobilis Rismavac+CA126 consists of a suspension of living, cultured avian cells containing at least 3.0 log10 PFU Marek's Disease virus (strain CVI 998) and at least 3.0 log10 PFU Turkey Herpes Virus (strain FC 126) per dose. The vaccine contains stabilisers and traces of antibiotics (neomycin and polymyxin or gentamycin, and amphotericin B).
Indications for use
Nobilis Rismavac+CA126 is for active immunisation of chickens to reduce mortality, clinical signs and lesions after infection with Marek’s disease virus (MDV).
Poultry - meat 0 days
Ampoules containing 1,000 or 2,000 doses supplied together with Nobilis Diluent CA (Vm 01708/4270).
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018